|
|
|
|
|
Russel Falck, MA, Robert G. Carlson, PhD, Jichuan Wang, PhD, and Harvey Siegal, PhD. Community Health, Wright State University, 3640 Colonel Glenn Hwy., Dayton, OH 45435, 937-775-2066, russel.falck@wright.edu
Depression has been identified as a disorder of clinical significance among MDMA/ ‘Ecstasy’ users. Even so, its prevalence among young adult users is uncertain. This research employs a cross-sectional design to determine the prevalence of current depressive symptomatology among a community sample of 402 young adults, aged 18-30 years, who reported having used MDMA on at least one occasion in the six months prior to study entry. Study participants were recruited through a respondent driven sampling plan that was implemented in a metropolitan area in central Ohio. Trained interviewers administered a questionnaire in an office setting. The instrument included a host of sociodemographic and drug use variables. In addition, the Beck Depression Inventory (BDI-II) was used to assess current depressive symptomatology. Univariate statistics are used to describe the sample and the prevalence of symptoms. Cumulative logistic regression analysis is used to identify the odds of having minimal, mild, moderate, or severe depression. The role of recency and frequency MDMA use is examined. The findings of this study have implications for prevention and treatment programs targeting MDMA users.
Learning Objectives: Learning objectives
Keywords: Drug Use, Depression
Presenting author's disclosure statement:
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.